Mike King appointed the Daljit S. and Elaine Sarkaria Professor of Biomedical Engineering
The Department of Biomedical Engineering is pleased to announce that Professor Michael King has been appointed the Daljit S. and Elaine Sarkaria Professor of Biomedical Engineering in recognition for his outstanding accomplishments in research, teaching, and service.
Michael King joined BME at Cornell in 2008 as an Associate Professor and promoted to Full Professor in 2012. In 2002, he began his academic career in BME at the University of Rochester, where he initially earned his B.S. in Chemical Engineering (1995). Thereafter, he received his Ph.D. from Notre Dame (1999) and completed his postdoctoral training at the University of Pennsylvania before returning to Rochester. He currently serves as the Editor-in-Chief of Cellular and Molecular Bioengineering, an official journal of the Biomedical Engineering Society.
Professor King employs tools and concepts from engineering to understand biomedically important processes that occur in the bloodstream, including cancer metastasis, inflammation, and thrombosis. His group identified that tumor cells in the circulation can mimic the physical mechanisms used by white blood cells to traffic through the body and adhere to the blood vessel wall, and they have explored strategies to interrupt this metastasis process by targeting specific adhesion receptors. Microscale flow devices developed in their laboratoryrecreate the complex microenvironment of the circulation where inflammation and cancer metastasis occur. They have invented new biomaterial surfaces based on natural halloysite nanotubes, that capture rare circulating tumor cells (CTCs) from blood while simultaneously repelling white blood cells. This nanotube-based flow system has gained widespread attention since the system can be easily adopted by clinical labs and recreates the natural rolling process that CTCs follow in the body.
Professor King has made numerous contributions to the Cornell community and nationally. He has published a successful textbook, chaired several faculty search committees, and served as editor-in-chief of "Cellular and Molecular Bioengineering" since 2013. His excellence in teaching and research has been recognized through multiple awards and honors including the College of Engineering’s Fiona Ip Li ’78 and Donald Li ’75 Excellence in Teaching Award, the American Association of Clinical Chemistry’s (AACC) Outstanding Speaker Award, and election to the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows. His cancer research has received national recognition and continues to grow in importance and impact.
Please join us in congratulating Professor Mike King on this well-deserved recognition.